Mytrex Health Technologies, Inc. (4431.TWO)
- Previous Close
20.95 - Open
21.55 - Bid 21.50 x --
- Ask 21.90 x --
- Day's Range
21.45 - 21.60 - 52 Week Range
14.50 - 32.50 - Volume
27,050 - Avg. Volume
46,787 - Market Cap (intraday)
785.515M - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
-- - EPS (TTM)
-2.25 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 14, 2021
- 1y Target Est
--
Mytrex Health Technologies, Inc. engages in the manufacturing, processing, and sale of various filter non-woven fabrics in Taiwan, rest of Asia, Europe, and internationally. The company provides electrostatic filtration materials for medical and industrial mask media, and other filtration applications; and composite nonwoven products for coolant and air filter, vacuum filter bag, HEPA and cabin filter, and water filtration compound material applications. It also offers thermal insulation products for glove, sock, shoe, hat, clothing material, and mask insulation material applications; and linen laundry and leasing, logistic, and medical supplies for hospitals. In addition, the company sells pharmaceuticals and medical hygiene materials; and manages medical clothing products. Mytrex Health Technologies, Inc. was founded in 1990 and is based in Taoyuan, Taiwan.
www.mytrex.com.twRecent News: 4431.TWO
View MorePerformance Overview: 4431.TWO
Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4431.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4431.TWO
View MoreValuation Measures
Market Cap
767.25M
Enterprise Value
716.19M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.44
Price/Book (mrq)
1.28
Enterprise Value/Revenue
0.41
Enterprise Value/EBITDA
41.41
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.68%
Return on Assets (ttm)
-4.03%
Return on Equity (ttm)
-13.19%
Revenue (ttm)
1.76B
Net Income Avi to Common (ttm)
-82.38M
Diluted EPS (ttm)
-2.25
Balance Sheet and Cash Flow
Total Cash (mrq)
277.52M
Total Debt/Equity (mrq)
36.83%
Levered Free Cash Flow (ttm)
27.06M